Filing Flows › Acadia Healthcare Company (ACHC) › Stock forecast & fair value
Acadia Healthcare Company (ACHC) stock forecast and fair value
Acadia Healthcare Company (ACHC) trades at $37.00. 14 analysts' median price target is $37.50 (+1%), from $19.00 to $45.00. Across 10 valuation methods the middle fair value is $38.47 (+4%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| EV/Sales vs peers | $17.84 | $46.99 | $82.78 | +27% |
| EV/Sales vs peers, weighted | $24.38 | $44.85 | $61.82 | +21% |
| EV/Sales vs peers, matched | $15.07 | $44.65 | $75.68 | +21% |
| Residual income | −$9.18 | −$9.36 | −$9.56 | -125% |
| Analysts' price targets | $19.00 | $36.07 | $45.00 | -3% |
| Shareholder yield (dividends + buybacks) | $8.26 | $9.69 | $11.72 | -74% |
| Tangible book (asset value) | $4.73 | $5.91 | $5.91 | -84% |
| Stage-weighted value (decline / turnaround) | $10.69 | $24.58 | $40.85 | -34% |
| Combined forecast (3 months) | $30.30 | $38.47 | $47.67 | +4% |
| Earnings power value (EPV) | $86.13 | $101.86 | $122.85 | +175% |
Acadia Healthcare Company's latest quarter
Acadia Healthcare Company, Q3 2026: revenue $895M (+5% year over year), operating margin 6.3%, net earnings $34.5M, operating cash flow $97.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for ACHC stock?
The median of 14 analysts' 12-month targets is $37.50, +1% from $37.00; the range is $19.00 to $45.00. The average rating is buy.
What is Acadia Healthcare Company's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between −$9.36 and $101.86, with a middle value of $38.47 against a price of $37.00. Each method's assumptions are on the page.
Does Acadia Healthcare Company usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is ACHC stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.